We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
AUM
$741M
AUM Growth
+$76.4M
Cap. Flow
+$59.4M
Cap. Flow %
8.01%
Top 10 Hldgs %
55.75%
Holding
150
New
12
Increased
86
Reduced
37
Closed
1

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.2%
2 Technology 7.03%
3 Industrials 1.15%
4 Financials 1.13%
5 Energy 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCIT icon
1
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$69.5B
$84M 11.34%
1,003,349
-11,358
-1% -$954K
CGMS icon
2
Capital Group US Multi-Sector Income ETF
CGMS
$5.43B
$63.8M 8.6%
2,308,168
+138,954
+6% +$3.85M
FNDF icon
3
Schwab Fundamental International Large Company Index ETF
FNDF
$26.4B
$49.9M 6.73%
1,103,954
+42,502
+4% +$1.88M
VIGI icon
4
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
$39.4M 5.32%
431,269
+13,164
+3% +$1.19M
VYMI icon
5
Vanguard International High Dividend Yield ETF
VYMI
$22.1B
$36.9M 4.98%
410,003
+15,777
+4% +$1.37M
ICSH icon
6
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.65B
$36.3M 4.9%
718,302
+632,528
+737% +$32M
MGV icon
7
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
$27.8M 3.76%
197,266
-936
-0.5% -$130K
VIG icon
8
Vanguard Dividend Appreciation ETF
VIG
$112B
$25.7M 3.47%
116,970
+2,328
+2% +$509K
VHT icon
9
Vanguard Health Care ETF
VHT
$19B
$25.3M 3.42%
87,982
+2,047
+2% +$572K
SCHD icon
10
Schwab US Dividend Equity ETF
SCHD
$111B
$24M 3.24%
876,084
+7,726
+0.9% +$210K
CGDV icon
11
Capital Group Dividend Value ETF
CGDV
$38.8B
$23.3M 3.15%
534,368
+7,097
+1% +$305K
XLF icon
12
State Street Financial Select Sector SPDR ETF
XLF
$54.3B
$22.8M 3.07%
415,774
+297
+0.1% +$15.8K
SPYM
13
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$18.7M 2.52%
232,631
+25,391
+12% +$2.02M
VIS icon
14
Vanguard Industrials ETF
VIS
$7.99B
$15.4M 2.08%
51,555
+334
+0.7% +$99.2K
MGC icon
15
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
$14.6M 1.97%
58,059
+491
+0.9% +$122K
AAPL icon
16
Apple
AAPL
$4.61T
$14.5M 1.96%
53,359
-1,020
-2% -$274K
VBR icon
17
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$11.5M 1.54%
54,068
+4,354
+9% +$912K
SCHF icon
18
Schwab International Equity ETF
SCHF
$70.2B
$10.5M 1.41%
435,130
+68,459
+19% +$1.63M
EFA icon
19
iShares MSCI EAFE ETF
EFA
$79.7B
$9.15M 1.23%
95,296
+3,835
+4% +$364K
VB icon
20
Vanguard Morningstar Small-Cap ETF
VB
$80.4B
$8.25M 1.11%
31,972
+8,620
+37% +$2.21M
EFV icon
21
iShares MSCI EAFE Value ETF
EFV
$32B
$8.13M 1.1%
113,882
+803
+0.7% +$55.8K
MSFT icon
22
Microsoft
MSFT
$3.67T
$7.86M 1.06%
16,255
+383
+2% +$192K
VOE icon
23
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$7.73M 1.04%
43,602
+1,241
+3% +$217K
QUAL icon
24
iShares MSCI USA Quality Factor ETF
QUAL
$47.1B
$7.24M 0.98%
36,446
+1,575
+5% +$309K
TWLO icon
25
Twilio
TWLO
$34.7B
$6.61M 0.89%
46,472

Similar funds

Capital Advantage's Q4 2025 Portfolio in Review

As of Q4 2025, Capital Advantage held 150 positions worth $741M, up 11% from $665M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Capital Advantage deployed $59.4M of net new capital in Q4 2025, opening 12 new positions and adding to 86 existing holdings. Its largest new stake was SoFi Technologies: 31,931 shares worth $836K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 86% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $954K trimmed.

  • Capital Advantage's largest Q4 2025 buy was SoFi Technologies: 31,931 shares worth $836K.
  • Capital Advantage added most to iShares Ultra Short Duration Bond Active ETF in Q4 2025, an estimated $32M increase.
  • Capital Advantage's biggest Q4 2025 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $954K.
  • Capital Advantage fully exited Pfizer in Q4 2025, selling an estimated $234K.
  • Capital Advantage's ten largest holdings make up 56% of its $741M portfolio in Q4 2025.
  • Capital Advantage opened 12 new positions and closed 1 in Q4 2025.
  • Capital Advantage's portfolio value rose 11% quarter-over-quarter to $741M.

Based on Capital Advantage's 13F filing for Q4 2025, filed 7 Jan 2026.